How Does Clover Health Company Work and What Drives Its Business Model?

Clover Health markets Medicare Advantage plans to eligible seniors and operates a data-driven care model built around the Clover Assistant, a decision-support platform for primary care physicians. Since late 2024 the firm also sells its analytics and machine-learning tools as standalone SaaS via Counterpart Health to external health systems.

Primary buyers are Medicare-eligible seniors selecting Medicare Advantage Clover Health plans and provider organizations or physician practices licensing the Clover Health technology platform and Counterpart Health SaaS for population health and risk adjustment.

Members receive affordable, comprehensive coverage with extra benefits (dental, vision) and lower out-of-pocket maximums; physicians get aggregated patient data and clinical-gap alerts to improve quality and capture accurate risk-adjusted payments.

Clover Health differentiates through its machine-learning driven Clover Assistant and Counterpart Health SaaS, which enable risk adjustment and proactive care management; this vertical integration supports both insurance revenue streams and technology licensing as growth drivers in 2025.

Clover Health receives monthly, per-member payments from CMS that are risk-adjusted for member acuity; these capitation payments drive the bulk of Clover Health revenue streams and determine cash inflows. In 2025 Clover Health targets a Medical Loss Ratio of 77 percent to 81 percent, meaning the company keeps the difference between premiums and medical claims as underwriting margin.

Clover Health's Counterpart Health SaaS sells technology licensing fees and analytics services to payers and providers; these contracts carry higher gross margins than the capital-intensive Medicare Advantage Clover Health insurance segment and reduce reliance on capitation. Tech revenue contributes growing recurring revenue and improves consolidated margin profile.

Clover Health monetizes demand through CMS capitation (per-member-per-month payment), risk-adjustment (machine learning and risk coding increases payment), and subscription or licensing fees from its Clover Health technology platform. Revenue also arises from care management fees, quality bonuses tied to Star ratings, and limited provider risk-sharing arrangements.

Revenue scales with Medicare Advantage Clover Health enrollment, members' CMS risk scores (higher acuity raises payments), and the company's ability to hold medical costs below premiums – hence the targeted 77 – 81 percent MLR for 2025. Growth in Counterpart Health licensing and improved coding accuracy (machine learning and risk adjustment) are key margin levers. Read more on governance in Ownership and Control of Clover Health Company.

High Star Ratings drive enrollment and bonus payments for Clover Health Medicare Advantage plans explained; maintaining above-average ratings supports capitated revenue and stabilizes margins.

Clover Health technology platform and machine learning for risk adjustment aim to lower medical loss ratio; in 2025 the insurer reported sustained improvement in insurance margins and positive adjusted EBITDA, validating the tech-first value-based care approach.

Enrollment remains concentrated in select states, so localized adverse selection or provider disputes can swing claims costs; Clover Health provider network and partnerships are narrower than national peers, raising operational leverage.

The business is highly sensitive to Medicare Advantage rate-setting and risk-adjustment policy changes; shifts in federal reimbursement or Star methodology could compress margins quickly and affect Clover Health revenue streams.

Transitioning the Clover Assistant into a standalone product via Counterpart Health creates non-capitation revenue and reduces reliance on Medicare payment swings; this diversifies how Clover Health makes money and monetizes the care-coordination tech.

Professional judgment: Clover Health has matured into a viable mid-tier insurer by 2025 with positive adjusted EBITDA and improving insurance margins, yet long-term valuation hinges on proving its technology yields superior clinical outcomes versus Humana and UnitedHealth; see Target Customers and Market of Clover Health Company for market positioning.